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Abstract  
 
Chirabite-AR was employed to differentiate enantiomers of the axially chiral cyclotriveratrylene 
(CTV)-derived macrocyclic lactam with baseline separation of most of the proton NMR 
resonances enabling enantiomeric purity determination of this supramolecular scaffold. 
Attachment of menthyloxy acetic acid as a chiral auxiliary to the CTV-Beckmann derived lactam 
afforded diastereomers that were enriched to a ratio of 87:13, as confirmed by both 1H NMR and 
single-crystal X-ray diffraction. Basic hydrolysis of the enriched diastereomeric mixture 
proceeded with rapid bowl inversion to yield racemic CTV-lactam as confirmed by Chirabite-AR 
NMR analysis. Density functional theory (DFT) calculations (M06 2X /6-31G*) were performed 
on the crown and saddle conformers of the CTV-lactam. 
 
 
Introduction 
Chiral cyclophanes have applications in enantiodiscrimination processes including catalysis, 
recognition and sensing, determination of enantiomeric excess, and signaling chiral information 
of guests,[1, 2] as with chiral molecular tweezers that exhibit selective binding and chiral 
recognition of specific guests.[3] Cyclotriveratrylene (CTV, 1)[4] is a natural product and was first 
isolated from the bark of Zanthoxylum conspersipunctatum found in New Guinea.[5] CTV and its 
[1.1.1]cyclophane congeners in their rigid crown conformation are unique bowl-shaped 
molecules that have applications in sensors, self-organized materials, liquid crystals, and 
metallosupramolecular chemistry.[6] CTV and its cryptophane derivatives are of great interest in 
molecular recognition.[7] They are members of a larger family of inherently axially chiral 
concave molecules that have applications in chiral recognition and asymmetric synthesis.[2] A 
chiral CTV derivative bearing Kemp’s triacid was shown to induce triple helix formation of 
collagen peptides.[8] A dynamic thermodynamic resolution strategy was recently reported of 
racemic CTV units by addition of remote stereogenic centers.[9] Helically chiral CTV units have 
been employed to construct enantiopure molecular cages,[10] along with a host of elegant CTV-
derived coordination cages.[11] Some of the fascinating supramolecular structures of self-
assembled cages derived from CTV-type scaffolds have recently been reviewed,[12] such as a 
racemic C3-symmetric bipyridyl-bearing CTV ligand with zinc shown to self-assemble into 
triply interlocked chiral catenanes within an overall chiral crystal.[13] CTV-based host 
compounds bearing three binaphthol moieties have been reported as chiral sensors with 
recognition of sugar derivatives.[14] 
 
The crown form of cyclotriveratrylene can undergo umbrella inversion that inverts chiral 
derivatives into their enantiomeric counterpart, as Collet demonstrated by observing the slow 
racemization of structurally chiral cyclotriveratrylene derivatives.[15] Resolution and NMR 
studies have been performed on the crown and saddle conformers of a CTV derivative toward 
chiral liquid crystals.[16]  
 
While most work with CTV has focused on peripheral functionalization, we have focused on 
apical functionalization, enabling attachment of CTV “bowl-out” receptors on surfaces,[17] 
including desymmetrized C1-symmetric derivatives that are also of interest.[18] The parent 9-
membered cyclophane 1 (Figure 1) is under ambient conditions locked into the bowl-shaped 
crown conformer. Elegant high temperature melt and quench experiments by Zimmerman first 
enabled isolation of the saddle conformer of CTV.[19] In contrast, the corresponding CTV 
monoketone 2 exists exclusively as the saddle conformer,[4] and resolves upon crystallization in a 
chiral conformation, as a racemic mixture of enantiomerically pure chiral crystals.[20] We 
discovered that the corresponding oxime 3 exists as a slowly equilibrating mixture of crown and 
saddle conformers that are separable,[21] and reported the kinetics and thermodynamics of their 
interconversion.[20] Furthermore, oxime 3 undergoes facile Beckman rearrangement to afford the 
macrocyclic lactam 4[22] which is axially chiral and thus potentially resolvable into its 
atropisomers.  
 
Current interest in synthetic macrocyclic receptors includes applications in chiral analysis and 
separation,[23] as well as in supramolecular chirality in self-assembled systems.[24] Ema has 
developed chiral selectors with multiple H-bonding sites in macrocyclic cavities[25-27] including 
the commercially available Chirabite-AR. While the macrocycle of CTV-lactam 4 contains a 
larger 10-membered ring, amide resonance[28] reduces flexibility through restricting rotation 
around the carbonyl C-N bond. We were interested if Chirabite-AR, which is designed for 
determining the enantiomeric purity of small molecules that can ideally be contained within its 
macrocycle, might be usable to determine the enantiomeric purity of larger supramolecular 
axially chiral scaffolds such as CTV-derived lactam 4. Furthermore, we addressed the possibility 
that lactam 4 might be resolvable via attachment of a chiral auxiliary through N-functionalization 
of lactam 4, given its ability[29] to undergo acylation in high yield to imide derivative 5. 
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Figure 1. Synthesis via Beckmann rearrangement of the 10-membered CTV-derived lactam 4 
enantiomers and conversion to N-acyl imide derivatives 5 and 6, and the structure of Chirabite-
AR 
  
 
Results and Discussion 
 
Toward the possible resolution of CTV-lactam 4, we first required a method to assess 
enantiomeric purity. Attempts to observe the separate enantiomers of racemic lactam 4 using 
chiral HPLC methods were unsuccessful, so we turned to chiral shift reagents. The racemic 
macrocyclic lactam 4 was treated with increasing amounts of the macrocyclic chiral shift reagent 
Chirabite-AR in CDCl3 solution and examined by 1H NMR spectroscopy, demonstrating that the 
individual enantiomers could be baseline separated by NMR for optical purity determination. 
The ratio of Chirabite-AR to lactam 4 was examined by varying the amount of Chirabite-AR 
from 0.01 equivalents to 0.3 equivalents. Some separation of enantiomeric resonances in the 
proton NMR was already evident with only 0.01 equivalents of Chirabite-AR, and 0.05 
equivalents were optimal to provide baseline separation of the proton resonances in the aromatic 
regions of the two enantiomers, while only 0.025 equivalents were required for baseline 
separation of some methoxy resonances. Additional quantities of Chirabite-AR were 
counterproductive, leading to large chemical shift displacements and compromising the ability to 
assign peaks. We surmise that Chirabite-AR is interacting most strongly with the lactam 
carbonyl oxygen, which bears a Mulliken charge of -0.489 au, the greatest point electron density 
on the molecule, and should be a strong H-bond acceptor for the H-bond donor moieties of 
Chirabite-AR. 
There are several regions of the 1H NMR spectra that provide peaks to track and integrate 
the CTV-lactam enantiomers in the presence of Chirabite-AR. Within the aromatic region (6.5-
7.3 ppm) shown in Figure 2, there were six clearly resolved Ar-H peaks that were split into 
twelve separate resonances when 0.125 equivalents of Chirabite-AR were added. When 0.30 
equivalents of Chirabite-AR were utilized, the enantiomeric lactam NH resonances in this region 
can also be differentiated. Furthermore, the aromatic Ar-H peak at 6.7 ppm was clearly resolved 
giving near-baseline separation using a very low Chirabite-AR loading (0.05 eq). In the methoxy 
region from 3.7 to 4.05 ppm, shown in Figure 3, signals of nearly all methoxy moieties from 
both enantiomeric lactams were split into separate peaks, especially when using 0.175-0.20 
equivalents of Chirabite-AR. Importantly, the NMR resonances for Chirabite-AR itself did not 
overlap with any of the peaks for the CTV-lactam as most of the Chirabite-AR resonances 
appear beyond 7.27 ppm, a region which contains no peaks relating to CTV-lactam 4. 
 
Figure 2. The aromatic region of the proton NMR spectra (400 MHz, CDCl3) of CTV-lactam 4 
with increasing quantities of Chirabite-AR (0.01 to 0.30 equivalents). 
 
Figure 3. The methoxy-containing region of the proton NMR spectra (400 MHz, CDCl3) of 
CTV-lactam 4 with increasing quantities of Chirabite-AR (0.01 to 0.30 equivalents). 
Toward the possible resolution of CTV-lactam 4, several different chiral auxiliaries were 
explored for reaction with the lactam N-H of 4, including (1S)-(-)-camphanic chloride, (S)-(+)-α-
methoxy-a-trifluoromethylphenylacetyl chloride, diacetyl-L-tartaric anhydride, (S)-(+)-alpha-
methoxy-alpha-trifluoromethylphenylacetate, and ketopinic acid chloride, several of which did 
not provide N-acylated adducts under a number of conditions explored. However, reaction of (-)-
menthyloxyacetic acid chloride was successful in providing diastereomeric imide adducts in 
good yield when using an excess of (-)-menthyloxyacetic acid chloride in pyridine at reflux, 
providing an 86% yield of the desired imide 6 as an approximately 87:13 mixture of 
diastereomers based on 1H NMR integration. After aqueous workup and filtration through a bed 
of alumina, crystallization from hexane/DCM afforded a mixture of diastereomers in an 87:13 
ratio (Figure 4). Attempts to separate the diastereomers and to improve the diastereomeric purity 
by further recrystallization and/or achiral column chromatography techniques were unsuccessful. 
Recrystallization from DCM/hexane provided X-ray quality crystals but did not alter the 
diastereomeric ratio from 87:13, which was the same ratio obtained from ethyl acetate/heptane. 
Interconversion and equilibration of the diastereomers is not possible, since umbrella inversion 
of the bowl-shaped macrocycle would require the menthyloxyacetyl substituent to pass through 
the center of the bowl, which is not possible. The crystal structure obtained through X-ray 
crystallography of crystals from DCM/hexane (Figure 5) showed that the two diastereomers co-
crystallize as a solid solution in a ratio of 83.2 ± 0.3% to 16.8 ± 0.3% based on electron density, 
with very similar ratios of diastereomers in the solid state and in solution. The absolute 
configuration of the two bowl moieties is inverted and the two sections are related by a non-
crystallographic pseudo-mirror plane. As expected, the menthyloxyacetate units have identical 
absolute configurations, 1R,2S,5R, but are slightly shifted against each other (Fig. S1, S2). The 
structures obtained for both diasteromers are consistent with the molecular structures and 
absolute configurations expected. 
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Figure 4. Structures of menthyloxyimide 6a (major diastereomer) and 6b (minor diastereomer) 
   
Figure 5. Two views of the X-ray crystal structure of major diastereomer 6a (H atoms omitted). 
Ortep plots and figures showing disorder of 6a and 6b are given in the SI (Fig. S1 – S3).  
The type of disorder observed for 6 is not unprecedented. A similar behavior had been 
previously observed for the acetyl-substituted counterpart of 6, N-acyl imide derivative 5.[29] The 
latter had been crystallized as a racemic mixture, with molecules located on and bisected by a 
crystallographic mirror plane, thus inducing whole molecule disorder not too dissimilar from that 
observed for 6. The geometry and conformation of the CTV-imide section in 5 and 6 closely 
resemble each other. Both molecules have the bowl shaped appearance typical for CTV and its 
derivatives,[4, 6] and the CTV-imide sections are virtually superimposable (Figs S4), with only 
slight deviations for the outer substituents, mostly torsion angles of the methoxy groups. In 
menthyloxy-substituted lactam 6, all methoxy groups are in plane with the benzene rings to which 
they are substituted, as is usual for sterically unencumbered polymethoxy benzene derivatives.[30] 
In N-acetyl lactam 5, on the other hand, one of the methoxy substituents is twisted out of plane, to 
avoid an otherwise unfavorable close contact with the methyl group of a neighboring molecule in 
the crystal. The menthyloxyacetate chain in 6 has an all-trans extended conformation, and the 
menthyl group is aligned with its long axis roughly perpendicular to the plane of the N-acyl imide 
segment. The positions of the menthyl units in major 6a and minor 6b diastereomers are quite 
similar, with a slight shift induced by the different positions of the connecting oxygen atom in 6a 
and 6b. Intermolecular interactions and packing in N-acetyl lactam 5 and in menthyloxyacetyl 
lactam 6 are similar (Fig S1, S2). Packing interactions are dominated by intra- and intermolecular 
CH⋅⋅⋅O interactions, augmented by a small number of CH⋅⋅⋅π contacts, involving the aromatic C-
H groups, the bridging methylene CH2 units, the methoxy CH3 groups, and, for 6, the C-H, CH2 
and CH3 moieties of the menthyl substituents. The positions of the menthyl groups in 6a and 6b 
are close enough to each other to not seriously affect packing interactions between neighboring 
molecules, and no additional disorder induced by the unequal disorder onto neighboring molecules 
is resolved. Molecules in N-acetyl lactam 5 as well as in N-menthyloxyacetyl lactam 6 can both 
be described to be arranged in stacked-cup arrays, with the acetyl or menthyl group of one 
molecule located in the cavity of the bowl of another, leading to columnar assemblies. The larger 
size of the menthyl substituent in 6 extends the distance between the bowl segments within 
columns, from ca. 8.5 Å in 5 to 13.4 Å in 6.  
Toward the possible isolation of an enriched enantiomer of 4, cleaving the chiral 
menthyloxyacetyl auxiliary of the 87:13 mix of diastereomers of 6a/b was performed using 
aqueous LiOH in THF. Attempts to determine the rate of racemization (from ~87:13 to 50:50) of 
isolated lactam by optical rotation showed a rotation of 0° at the first time point reading, 
indicating rapid complete racemization within less than 15 minutes. This was confirmed by 
NMR methods using again Chirabite-AR as a chiral resolution aid. Hydrolysis of the chiral 
auxiliary was carried out on enriched CTV-menthyloxyacetic imide in aqueous THF using 
lithium hydroxide (3.5 eq) at < 5 °C for 15 minutes, then the reaction mixture was sampled, 
rapidly concentrated, redissolved in CDCl3 containing Chirabite-AR (0.30 equiv), and analyzed 
by 1H NMR. Examination of peaks of interest to monitor enantiomeric purity (Figure 6), 
specifically at 6.63/6.69 ppm and 6.51/6.53 ppm as indicated by the black circles correspond to 
the singlets in the racemic CTV lactam without Chirabite-AR as denoted in (A), and indicated a 
1:1 ratio of enantiomers, thus complete racemization. The chemical shifts of the separated 
enantiomers in (A) are noted to correspond closely to the shifts observed for lactam 4 with 0.175 
eq Chirabite-AR (C), rather than with 0.30 eq Chirabite-AR (D), presumably due to the excess 
hydroxide present in the reaction mixture that is competing with Chirabite and its interaction 
with lactam 4. These results indicate that once the chiral auxiliary is cleaved, the bowl inversion 
is quite rapid furnishing lactam 4 as a racemate, with a barrier to interconversion of less than 21-
25 kcal/mol, which was the barrier to interconversion determined for the crown and saddle 
conformers of CTV-oxime 3.[20]
 Figure 6. 1H NMR spectra for (A) in purple, lactam 4 without Chirabite; (B) in green, the lactam 
4 derived from basic cleavage of enriched 6a/b with 0.30 eq Chirabite with excess hydroxide 
showing a 1:1 ratio of singlets indicating racemic lactam 4; (C) lactam 4 in the presence of 0.175 
eq Chirabite; and (D) in blue, racemic lactam 4 with 0.30 eq Chirabite. 
 
Assessment of the relative energies of the crown and saddle conformers of lactam 4 were 
assessed through calculations on model structures 7a-c lacking the six methoxy groups (Figure 
7), since a saddle conformer must be an intermediate in inversion and racemization of the chiral 
crown conformer.[4] Density functional theory (DFT) calculations (M06 2X /6-31G*) on lactams 
7a-c were performed using Spartan ’16 (Wavefunction, Inc., Irvine, CA). It was found that the 
saddle conformer 7b is 7.1 kcal/mol higher in energy than the crown conformer 7a, and the side-
saddle 7c is 8.6 kcal/mol higher in energy than the crown 7a, consistent with the observation of 
only the crown conformer in the crystal structure of 5. We reported earlier for the 9-membered 
ring CTV oxime 3 that the saddle conformer is 3.15 to 5.23 kcal/mol (13.2 to 21.9 kJ/mol) higher 
in energy than the more stable crown conformer.[20] Thus the saddle conformers for the model 
lactam 7 that were examined are higher in energy than for the smaller macrocycle CTV oxime 3, 
yet the transition state to the saddle conformer must be easily surmountable at room temperature 
to enable racemization of CTV lactam 4. 
 
Figure 7: DFT energy minimized structures for lactam 7 crown and saddle conformers as a 
model for CTV-lactam 4 
In summary, we have demonstrated that Chirabite-AR can be used to differentiate the 
enantiomers of inherently axially chiral supramolecular scaffolds such as CTV-derived lactam 4, 
and have succeeded in attaching (-)-menthyloxy acetic acid as a chiral auxiliary to lactam 4 and 
enriching the diastereomeric ratio through crystallization, as confirmed by NMR spectroscopy 
and X-ray crystallography. Hydrolytic cleavage of the chiral auxiliary, however, returned 
racemic lactam 4, based on optical rotation and NMR analysis in the presence of Chirabite-AR. 
 
Experimental Section 
DFT Calculations 
Calculations at the density functional level of theory were performed using Spartan ‘016 by 
Wavefunction, employing the M06 2X functional and the 6-31G* basis set according to a 
previously-described protocol.[31]   
 10,15-Dihydro-2,3,7,8,12,13-hexamethoxy-5H tribenzo[a,d,g]cyclononen-5-one (CTV-
Monoketone) 2 
The procedure was improved from the previously-reported synthesis.[21] A 5-liter glass reactor 
(3-necked), equipped with an overhead mechanical stirrer, J-Kem thermocouple, heating mantle, 
reflux condenser, and nitrogen inlet was charged in the following order with CTV 1 (76.22 g, 
0.17 moles, 18 eq), ethyl acetate (2 L), activated manganese dioxide (264.7 g, 3.05 moles), 
ground potassium permanganate (241.1 g, 1.53 moles, 9 eq) and lastly ethyl acetate (0.29 L) as a 
rinse. The reaction was stirred at room temperature to ensure that there was no exotherm 
reaction. The mixture was then heated to reflux and stirred overnight. After 18 hours, TLC and 
HPLC analysis indicated that the reaction was complete. The reaction solution was colorless 
once solids settled indicating that all KMnO4 had reacted. The reaction mixture was cooled to 
50°C, filtered over a pad of Celite (70.6 g), and the Celite Cake was rinsed with ethyl acetate (3 x 
500 mL) and DCM (2 x 500 mL). The filtrate was concentrated under reduced pressure at 40-
50°C to give crude CTV-monoketone (61.91 g) as a pale yellow solid. The crude monoketone 
(51.00 g) was placed into a 250-mL glass reactor (2-necked), equipped with a large magnetic stir 
bar, J-Kem thermocouple, heating mantle, and reflux condenser. To the reactor was added 
acetonitrile (150 mL, HPLC grade). The mixture was heated to 70 °C and the slurry was stirred 
(250-300 rpm) at 70 °C for 18 hours. The slurry mixture was allowed to gradually cool to room 
temperature over 4 hours, then continued to stir at room temperature for approximately 3 hours. 
The slurry was filtered over a fitted funnel (medium porosity), the wetcake was washed with 
acetonitrile (60 mL), dried by suction, and further dried in vacuo at 60 °C overnight to give 
purified CTV monoketone 2 (32.54 g white solid, 65% yield). The mother liquor was partially 
concentrated to remove about 75% of the solvent to provide a slurry. The slurry was filtered and 
the wetcake was washed with ethyl acetate/heptane (50/50, 10 mL) and dried to give a second 
crop (15.8 g, 31% yield, white solids) of purified CTV-monoketone 2. The 1H NMR data are in 
accordance with those reported in the literature.[20] 
 
10,15-Dihydro-2,3,7,8,12,13-hexamethoxy-5H-tribenzo[a,d,g]cyclononen-5-oxime (CTV 
Oxime) 3, as a mixture of saddle and crown conformers 
In a modification of the reported[21] procedure, to a 500-mL glass reactor (3-necked), equipped 
with a magnetic stir bar, reflux condenser, J-Kem thermocouple, and nitrogen inlet, was added 
CTV-monoketone (19.00 g), hydroxylamine hydrochloride (42.64 g), and pyridine (190 mL). 
The mixture was heated to reflux (110 °C) under a nitrogen atmosphere. After 16.5 hours, the 
reaction was deemed complete by TLC analysis (EtOAc/DCM, 20/80) and the reaction was 
allowed to cool. Concentration gave a crude residue to which was added USP purified water (250 
mL) and the mixture was triturated at room temperature for 30 minutes. The slurry was filtered, 
and the wetcake was washed with USP purified water (2 x 50 mL), dried by suction, and further 
dried in vacuo at 50 °C overnight to provide a pure mixture of saddle and crown CTV-oximes as 
a white solid (17.63 g, 90%). Spectral data matched the reported literature.[21] 
 
2,3,8,9,13,14-Hexamethoxy-11,16-dihydrotribenzo[b,e,h]azecin-6(5H)-one (CTV-lactam) 4 
The previously-reported procedure[22] was modified to avoid thionyl chloride, and with good 
yield from a mixture of crown and saddle conformers. To a 1-liter 3-necked flask equipped with 
an overhead mechanical stirrer, nitrogen inlet, and J-Kem thermocouple was added CTV-oxime 
2 (10.00 g, 20.85 mmol) and acetonitrile (200 mL). The mixture was stirred at ambient 
temperature for 20 minutes, then carbonyldiimidazole (7.18 g, 44.28 mmol) was added. 
Additional acetonitrile (20 mL) was used to rinse contents off the reactor flask walls. After 1 h at 
rt, TLC analysis (EtOAc/DCM, 80/20) revealed that the oxime starting material was completely 
consumed and a new spot appeared (oxime O-acyl imidazole intermediate, Rf = 0.10). The 
reaction mixture was cooled to < 5 °C and de-ionized water (50 mL) was added followed by 
drop-wise addition of trifluoroacetic acid (TFA, 50 mL) over 20 minutes using a dropping 
funnel. After 20 h at room temperature, TLC analysis (EtOAc/DCM, 80/20) showed complete 
conversion of the acyl imidazole intermediate to CTV-lactam (Rf = 0.18). To the reaction 
mixture was added drop-wise de-ionized water (600 mL) over 30 minutes to provide an opaque 
pink slurry which was allowed to stir for 20 hours and then filtered. The wetcake was washed 
with water (50 mL), suction dried, and further dried in vacuo at 50 °C to provide CTV-lactam 4 
(8.13 g, 81.3%). HPLC purity (220 nm): 95.2%. Spectra were identical to reported literature.[22] 
 
5-[1,2,3,4-Tetrahydro-1-[[[(1R,2S,5R)-5-methyl-2-(1-
methylethyl)cyclohexyl]oxy]acetyl]-]acetyl-11,16-dihydro-2,3,8,9,13,14-hexamethoxy-
tribenz[b,e,h]azecin-6(5H)-one (menthyloxyacetyl CTV-derived lactam) 6  
To a solution of CTV lactam 4 (175 mg, 0.36 mmol) in pyridine (1.8 mL) was added (-)-
menthyloxyacetic acid chloride (913 mg, 3.92 mmol) at room temperature and the solution was 
heated to reflux for 2 h. The mixture was then concentrated under reduced pressure, and the 
resulting residue was diluted in dichloromethane and poured onto ice. The layers were separated, 
and the aqueous layer was extracted two additional times with dichloromethane. The combined 
organic layers were washed successively with 1N hydrochloric acid (2x), saturated aqueous 
sodium bicarbonate, distilled water, brine, dried over sodium sulfate and concentrated to afford 
the crude product as a solid (999 mg). The mixture was passed through neutral alumina (17 g) 
eluting with ethyl acetate/dichloromethane (20/80) to remove excess menthyloxyacetic acid, 
followed by elution of the cyclotriveratrylene lactam starting material that was recovered (40 mg, 
25% recovered). The remaining material (477 mg) eluted from the alumina was 
chromatographed on silica gel (24 g) eluting with a gradient from pure dichloromethane to ethyl 
acetate/dichloromethane (50/50) to afford the desired imide 6 (167 mg, 69%) as a pale yellow 
solid. The product was crystallized using DCM and hexane yielding an 87:13 mixture of 
diastereomers: mp 200-203 °C; [α]D = -218° (c = 2.4 g/100 mL); IR 2998.6, 2953.5, 2927.6, 
2868.3, 1723.0, 1696.3, 1608.0 , 1517.9, 1463.1 cm-1. 1H NMR (400 MHz, CDCl3): δ 6.87 (bs, 
2H), 6.71 (bs, 0.12H), 6.69 (bs, 0.11H), 6.68 (bs, 0.11H), 6.67 (bs, 0.13H), 6.60 (bs, 0.22H), 
6.59-6.52 (complex, 3.2H), 6.47 (bs, 0.13H), 6.46 (bs, 0.13H), 6.39 (bs, 0.45H), 6.38 (bs, 
0.55H), 5.07 (bs, 0.19H), 5.03 (bs, 0.26H), 4.98-4.84 (m, 0.87H), 4.80 (bs, 0.27H), 4.76 (0.20H), 
4.47 (bs, 0.03H), 4.42 (bs, 0.04H), 4.37 (bs, 0.04H), 4.32 (bs, 0.31H), 4.29 (bs, 0.28H), 4.26 (bs, 
0.24H), 4.23 (0.26H), 4.16 (bs, 0.04H), 4.13-4.11 (complex, 0.27H), 4.10-4.05 (complex, 
0.45H), 4.04-4.02 (complex, 0.52H), 4.01-3.97 (complex, 0.43H), 3.95-3.91 (complex, 6.2H), 
3.90 (bd, 1H), 3.87 (bd, 1H), 3.83 (bs, 1H), 3.81 (bs, 0.43H), 3.80-3.78 (complex, 1.2H), 3.74 
(bd, 3.2H), 3.73 (bs, 3.2H), 3.71-3.60 (complex, 6.4H), 3.62-3.58 (complex, 1H), 3.55 (bd, 1H), 
3.49 (bs, 0.30H), 3.45 (bd, 0.54H), 3.42 (bs, 0.28H), 3.33-3.27 (td, 1.1H), 3.20-3.07 (complex, 
0.32H), 2.41-2.24 (complex, 1.35H), 2.25-2.19 (complex, 1.23H), 2.12-2.00 (complex, 0.55H), 
1.68-1.58 (complex, 5.4H), 1.46-1.18 (complex, 8H), 1.08-0.71 (complex, 22.2H). 13C-NMR (75 
MHz, CDCl3): δ 16.1, 16.2, 16.3, 20.9, 21.0, 21.1, 21.9, 22.1, 22.3, 23.2, 23.3, 25.4, 25.5, 25.6, 
29.6, 31.5, 33.8, 33.9, 34.2, 34.4, 34.5, 35.7, 35.8, 40.0, 40.2, 48.2, 48.3, 55.5, 55.6, 55.7, 55.8, 
55.9, 56.0, 56.1, 56.2, 70.9, 71.2, 76.6, 77.0, 77.2, 77.4, 80.1, 80.5, 80.6, 109.2, 109.4, 111.2, 
111.3, 111.5, 111.6, 111.7, 111.9, 112.1, 112.2, 112.5, 113.6, 114.2, 114.3, 115.4, 127.5, 128.1, 
128.8, 129.9, 130.0, 130.5, 130.8, 131.0, 131.1, 131.3, 146.8, 147.4, 147.7, 147.8, 148.3, 148.8, 
149.6, 173.4, 174.4. MS: Cald for C39H50NO9 [M+H]+: m/z 676.3, found 676.3. 
 
Hydrolysis of CTV Lactam menthyloxy imide 6 and the use of Optical Rotation to 
determine resolution of CTV-Lactam 4 
To the 87:13 mixture of menthyloxy CTV lactam diastereomers 6 in 3:1 THF/water (0.75 mL) at 
0 °C was added lithium hydroxide (3 mg, 0.91 mmol) and the reaction was stirred for 15 
minutes. The mixture was extracted three times with dichloromethane. The combined organic 
layers were washed once each with distilled water and brine, filtered over sodium sulfate, and 
concentrated to afford a solid (24 mg), which was filtered through alumina eluting with 2/8 ethyl 
acetate/dichloromethane to isolate the cleaved CTV lactam 4 (17 mg): [α]20D  = 0° (c=3.4, DCM). 
 
Hydrolysis of menthyloxy CTV lactam diastereomers 6 and the use of Chirabite-AR to 
determine enantiomeric purity of CTV-Lactam 4 
The 87:13 mixture of menthyloxy CTV lactam diastereomers 6 (13.2 mg, 0.019 mmol) was 
dissolved in THF (0.75 mL) and then cooled to 0-5 °C using an ice-water bath. A solution of 
0.24 M lithium hydroxide monohydrate (0.27 mL, 0.068 mmol, 3.5 eq) was added. The mixture 
was stirred at 0-5 °C for 15 minutes, then the reaction mixture was transferred to a 20 mL 
scintillation vial and concentrated under high vacuum for 5 minutes. The residue was dissolved 
in CDCl3 (0.75 mL) followed by the addition of 0.10 M Chirabite-AR solution in CDCl3 (60 µL, 
0.006 mmol, 0.3 eq) and this mixture was placed in an NMR tube and an NMR was obtained 
within 2 min. 1H NMR analysis revealed that the mixture was racemic based on 1:1 integration 
of the two peaks at 6.51 and 6.53 ppm and by the 1:1 peak height.  
 
Chirabite-AR Study with Racemic CTV-Lactam 4 
To a solution of the racemic CTV-lactam 4 (20 mg, 0.042 mmol) in CDCl3 (1.0 mL) in a 400 
MHz tube was added a solution of 0.10 M Chirabite-AR in CDCl3 prepared by mixing Chirabite-
AR (38 mg, 0.05 mmol) in CDCl3 (0.5 mL). The equivalents of Chirabite-AR that were 
evaluated were 0.01, 0.025, 0.050, 0.075, 0.10, 0.125, 0.150, 0.175, 0.20, and 0.30 eq. After 
addition of the specified amount of Chirabite-AR solution into the NMR sample containing 
racemic CTV-lactam, the sample was placed into the NMR spectrometer, analyzed, and then the 
next charge of Chirabite-AR solution was added followed by NMR analysis in sequential order. 
 
 
Supporting Information 
Supporting information and ORCID(s) from the author(s) for this article are 
available on the WWW under https://doi.org/???. CCDC-1844285 contains the supplementary 
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Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif. 
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